Investor Name | Invest Money | Lead Investor | Propotion | |
---|---|---|---|---|
National Institutes of Health | - | Yes | - | Detail |
Announced Date | Round | Money Raised | Investors | |
---|---|---|---|---|
Feb 27, 2012 | Post-IPO Equity | $ 83.70M | Biolding Investment,Naxyris,etc. | Detail |
Sep 28, 2010 | Post-IPO Equity | $ 13.77M | TotalEnergies Ventures | Detail |
Oct 12, 2006 | Series A | $ 20M | Khosla Ventures,Kleiner Perkins,etc. | Detail |
Feb 7, 2008 | Series Unknown | $ 2.35M | Detail | |
Jun 11, 2013 | Post-IPO Debt | $ 30M | Detail | |
Jun 26, 2010 | Series D | $ 133M | Cosan S.A.,Procter & Gamble Company,etc. | Detail |
Jul 31, 2014 | Post-IPO Debt | $ 10.85M | Detail | |
Aug 14, 2008 | Series B | $ 21M | DAG Ventures,Khosla Ventures,etc. | Detail |
Oct 14, 2015 | Post-IPO Equity | $ 57.60M | Detail | |
Oct 6, 2016 | Post-IPO Equity | $ 5M | Detail | |
May 23, 2014 | Post-IPO Equity | $ 75M | Detail | |
Apr 22, 2014 | Post-IPO Equity | $ 4M | Detail | |
Jul 29, 2015 | Post-IPO Equity | $ 140.97M | Temasek Holdings,Total,etc. | Detail |
Sep 19, 2007 | Series B | $ 70M | DAG Ventures,Khosla Ventures,etc. | Detail |
Oct 6, 2016 | Post-IPO Debt | $ 25M | Detail | |
Oct 1, 2009 | Series C | $ 41.75M | Khosla Ventures,Kleiner Perkins,etc. | Detail |
Oct 28, 2011 | Post-IPO Equity | $ 7M | Detail | |
Aug 3, 2017 | Post-IPO Equity | $ 50M | DSM,Vivo Capital | Detail |
Dec 1, 2009 | Grant | $ 24.30M | Detail | |
Sep 28, 2010 | IPO | $ 84.80M | Detail |